This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend Cardiovascular Professional Care

2023 Conference Programme

Subpage Hero


Theatre H: CvPC Clinical
  1. Enhancing the Recognition and Care of ATTR-CM: Addressing an Underdiagnosed Condition
    This educational symposium was sponsored by Alnylam Pharmaceuticals UK.   NP-UK-00306|November 2023
  2. This presentation covers the important role of primary care in the diagnosis, management and monitoring of heart failure in primary care supported by relevant national and international guidelines.
  3. This is a promotional symposium sponsored and organised by AstraZeneca, intended for GB HCPs only.
  4. Optimal modern management for CV risk reduction in secondary prevention
  5. We will demonstrate CVDACTION, the new smart data tool for targeted case finding and at-scale treatment optimisation in high risk conditions such as blood pressure, cholesterol, diabetes and chronic k ...
Theatre I: CvPC Clinical
  1. What is the ECG? a brief history and overview. Bedside interpretation of the ECG. New developments in automated analysis, AI, and newer forms of ECG (signal averaged, telemetry, intracardiac).
  2. Digital tools to support patients with Cardiovascular disease
    Nationally over 30,000 patients have been supported with digital tools to manage cardiovascular diseases. Learn more about how digital technology can support the identification and ongoing management ...
  3. The recent ESC Guidelines on Preventing Coronary Heart Disease in Adults with Congenital Heart Disease are a huge step forward. This presentation will explore the opportunities and challenges in trans ...
  4. A digital NHS Health Check was developed and tested in one local authority area. Feasibility was assessed using quantitative and qualitative data: non-identifiable patient-level data (n=2036); online patient surveys (n=109); patient semi-structured one-to-one interviews (n=37); stakeholder semi-structured one-to-one interviews (n=11). These data highlighted a range of challenges to consider for future developments of such models, leading to recommendations around set up, patient invitations, more flexible models for patient completion and engagement with their NHS Health Check results.
  5. Aim To promote excellence in cardiovascular nursing Our Mission BANCC is the national voice for all nurses involved in the care of people with cardiovascular health, science and disease. Our aim is to promote and support nurses who work with cardiovascular patients. We aim to achieve this through 1) national representation and collaboration 2) sharing evidence-based practice 3) supporting professional development.
Theatre H: CvPC Clinical
  1. This session will highlight the Cardiovascular disease prevention ambitions for England and show how far we have come in delivering against these ‘ABCs’. The key challenges facing primary care in deli ...
  2. This is a promotional symposium sponsored and organised by AstraZeneca, intended for UK HCPs only.
  3. This talk focuses on diagnosis, risk stratification and management of ACS, aimed at a target audience of clinicians working in emergency departments, acute medicine and cardiology.
Theatre I: CvPC Clinical
  1. Patients with thalassaemia and sickle cell disease experience multiple cardiac issues. This presentation will provide basis concepts of cardiac involvement in haemoglobinopathies and how to manage them.
  2. An understanding of the impact of frailty in the setting of cardiovascular disease (and diabetes) Clinical considerations when managing adults with frailty (in the setting of CVD/diabetes) Understand ...
  3. Integrating digital technology into practice:  Ai led remote ECG monitoring -  Benefits & Outcomes
    This session will review the growth of wearable and remote ECG diagnostics, from consumer devices such as apple watch and Kardiamobile, through to the professional diagnostics that iRhythm Zio XT deli ...
  4. Coronary heart disease kills more than 23,000 women in the UK every year, yet the perception that coronary heart disease is a man's disease persists. In 2022, Heart Research UK launched the HER Diseas ...
  5. The presentation covers the current knowledge of the complex mechanisms controlling the crosstalk between adipose tissue and the cardiovascular system and their clinical implications.
  6. Understand the epidemiology and impact of obesity in the UK and worldwide Understand the association between obesity and CVD Consider the management of obesity in the setting of CVD including diet, me ...

Sponsors & Partners

Event Supporter


Newsletter Sign Up